Omnia Family Wealth LLC Has $444,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Omnia Family Wealth LLC cut its stake in shares of Colgate-Palmolive (NYSE:CL) by 10.6% during the fourth quarter, Holdings Channel reports. The firm owned 5,576 shares of the company’s stock after selling 662 shares during the quarter. Omnia Family Wealth LLC’s holdings in Colgate-Palmolive were worth $444,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Vest Financial LLC raised its position in Colgate-Palmolive by 25.1% during the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock valued at $29,498,000 after buying an additional 74,337 shares during the period. Central Bank & Trust Co. grew its stake in Colgate-Palmolive by 22.1% in the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after purchasing an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC grew its stake in Colgate-Palmolive by 9.2% in the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after purchasing an additional 910 shares in the last quarter. Sarasin & Partners LLP grew its stake in Colgate-Palmolive by 1.2% in the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock valued at $323,115,000 after purchasing an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC grew its stake in Colgate-Palmolive by 2.5% in the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock valued at $571,000 after purchasing an additional 172 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

CL stock traded up $1.72 during midday trading on Friday, reaching $91.01. 7,541,541 shares of the company were exchanged, compared to its average volume of 3,968,951. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. The business has a 50-day moving average price of $87.66 and a two-hundred day moving average price of $81.54. Colgate-Palmolive has a one year low of $67.62 and a one year high of $92.25. The firm has a market capitalization of $74.81 billion, a price-to-earnings ratio of 28.80, a price-to-earnings-growth ratio of 3.42 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The firm had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the previous year, the business posted $0.73 earnings per share. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. Equities research analysts forecast that Colgate-Palmolive will post 3.5 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.20%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on CL shares. Evercore ISI increased their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research note on Monday, April 8th. The Goldman Sachs Group assumed coverage on shares of Colgate-Palmolive in a report on Friday, March 1st. They set a “buy” rating and a $93.00 price objective on the stock. Wells Fargo & Company increased their price objective on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a report on Monday, January 29th. Raymond James raised shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price on the stock in a research note on Monday, January 29th. Finally, Stifel Nicolaus increased their price target on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the company a “buy” rating in a research report on Wednesday, April 10th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus price target of $89.50.

Insider Transactions at Colgate-Palmolive

In related news, CEO Noel R. Wallace sold 29,772 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $84.06, for a total value of $2,502,634.32. Following the completion of the transaction, the chief executive officer now owns 301,343 shares of the company’s stock, valued at $25,330,892.58. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 69,948 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the transaction, the chief executive officer now owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Noel R. Wallace sold 29,772 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $84.06, for a total value of $2,502,634.32. Following the transaction, the chief executive officer now directly owns 301,343 shares of the company’s stock, valued at approximately $25,330,892.58. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 232,371 shares of company stock valued at $19,505,099. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.